Metformin Hydrochloride 500 mg + Glimepiride 1 mg PR Tablets – GLIMRIL M1

Metformin Hydrochloride 500 mg + Glimepiride 1 mg PR Tablets  – Balanced Diabetes Control, Dual Action Formula.

GLIMRIL M1 – Glimepiride 1 mg + Metformin Hydrochloride 500 mg PR Tablets is a bilayered tablet that combines Glimepiride, a sulfonylurea that stimulates insulin secretion from the pancreas, and Metformin, a biguanide that decreases hepatic glucose production and improves insulin sensitivity. The prolonged-release (PR) formulation of Metformin ensures a gradual and sustained release, leading to better blood sugar control while minimizing gastrointestinal discomfort.

Recommended by Specialists:
✅Diabetologists – For long-term Type 2 Diabetes Mellitus (T2DM) management and insulin resistance.
✅General Physicians (GPs) – To help regulate fasting and postprandial blood glucose levels effectively.

Key Benefits of Metformin Hydrochloride 500 mg + Glimepiride 1 mg PR Tablets – GLIMRIL M1:
✅Comprehensive Blood Sugar Management – Glimepiride enhances insulin secretion, while Metformin improves insulin sensitivity and reduces excess glucose production.
✅Bilayered Tablet for Efficient Absorption – Ensures immediate Glimepiride release for rapid action and prolonged Metformin release for sustained glycemic control.
✅Better Gastrointestinal Tolerance – The PR formulation of Metformin reduces the risk of stomach-related side effects, improving patient compliance.
✅Minimized Risk of Hypoglycemia – At controlled doses, Glimepiride offers a balanced approach, lowering blood sugar levels with a reduced risk of hypoglycemia compared to other sulfonylureas.

Indications:
✅Type 2 Diabetes Mellitus (T2DM) Management
✅Regulation of Fasting & Postprandial Blood Glucose
✅Management of Insulin Resistance in T2DM
✅Stable Glycemic Control with Fewer Side Effects